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More than 200 million women in the developing world want to  
prevent pregnancy but are not using modern contraception. 
For many of these women, particularly the poor, significant structural barriers ob-
struct their access to the full range of contraceptive methods. Women's desire to 
delay, space, or limit pregnancies is often resisted by their families or communities. 
Public-sector family planning programs, which are the main source of contraception 
in most developing countries, typically offer limited options, and supplies are not al-
ways in stock. Health care providers may not be trained to provide the counseling 
and services that women need to achieve their reproductive goals. These factors 
leave poor women facing a substantial risk of unintended pregnancy, unsafe abor-
tion, and maternal and infant mortality and morbidity. 
Highly effective, long-acting, reversible contraceptives (LARCs) such as  
the intrauterine contraceptive device (IUD) and contraceptive implants  
often are out of reach for women in developing countries. 
Because of the need for a skilled provider and the low priority given to making these 
methods a viable option for women, family planning programs often fail to offer 
women a full range of methods, including those that are most effective and appropri-
ate for women who want to postpone their first pregnancy, delay their next pregnan-
cy, or limit future births. 
Globally, more than 40 percent of pregnancies are unintended. Two-thirds of these 
pregnancies could be prevented if women with an unmet need for contraception  
had access to their choice of safe and effective methods. Having access to a variety 
of contraceptive options and services based on informed choice allows women to 
choose the method best suited to their needs. Because highly effective, long-acting, 
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BELLAGIO CONSENSUS: 
RECOMMENDATIONS FOR ACTION TO INCREASE ACCESS TO  
HIGHLY EFFECTIVE, LONG-ACTING, REVERSIBLE CONTRACEPTION 
 
International experts meet to discuss ways to increase access to highly effective, long-acting, reversible contraception (LARCs). The meeting was 






reversible contraceptives maintain their effectiveness for a long period, temporary supply 
chain disruptions have little impact on users' lives. Likewise, LARCs typically cost less per 
month of use than less-effective reversible contraceptives. For example, because of their 
more prolonged use and higher effectiveness, copper IUDs cost substantially less per 
month of use to prevent an unintended pregnancy than other reversible methods. Further, 
development of new implants and improved pricing options for existing implants and intra-
uterine contraceptive systems (IUSs) would make the cost of their use comparable to that 
of other contraceptive products in many national markets. 
 
Since 1984, international agreements have reaffirmed the right of women to decide on the 
number and timing of their children as well as the means to achieve these intentions. If 
access to LARCs such as intrauterine contraception (IUSs or IUDs), implants, and, in the 
future, longer-acting contraceptive vaginal rings and injectables were increased, unin-
tended pregnancies could be significantly reduced and women's health significantly im-
proved. LARCs are more effective than other contraceptive methods in reducing the prob-
ability of unintended pregnancy. Consequently, greater use of LARCs would reduce the 
number of unintended pregnancies and unsafe abortions, and improve maternal and in-
fant health. In addition to these health benefits, meeting women's contraceptive needs 
would help increase their economic opportunities and their contributions to their families’ 
well-being as well as to national economic growth through greater income per capita. 
 
The need for LARCs will continue to grow. Because of the young age structure of popula-
tions in developing countries, the number of potential users of contraception will increase 
from 144 million in 2005 to about 214 million by 2020. Of these, we estimate that approx-
imately 57 million women will be seeking LARCs by 2020. Research on policies and pro-
grams has demonstrated that the use of LARCs increases when women are provided with 
greater method choice and a concern for equity shapes the design of health care delivery 
strategies. The success of these programs provides evidence for the continued expansion 




In May 2012, the Population Council, the 
International Federation of Gynecology 
and Obstetrics (FIGO), and the Reproduc-
tive Health Supplies Coalition (RHSC)  
hosted a meeting at the Rockefeller  
Foundation's Bellagio Center to discuss 
opportunities to increase access to LARCs 
to accelerate progress toward meeting the 
Millennium Development Goal of universal access to reproductive health services. Partici-
pants, including service providers, donor representatives, policymakers, procurement spe-
cialists, manufacturers, and public health officials, reached consensus on the following 
analysis and recommendations. 
 
We believe that women are qualified 
to make informed choices about the 
contraceptive that best meets their 
needs, if access is provided, correct 
information is available, and quality 
of care is ensured. 
3 
Access to all contraceptives, including LARCs, must be based upon the right of women and 
men to the full range of reproductive health services. The compelling public health and 
economic benefits of expanding women's access to LARCs require new policies and pers-




Change policies: Policymakers should increase the priority given to efforts to reduce unintended pregnancies by 
meeting the unmet need for highly effective, long-acting, reversible contraceptive methods as 
part of a comprehensive range of method options. This priority should be reflected in financing, 
procurement, and human resource policies as well in the registration, introduction, and distri-
bution of contraceptive methods. 
Reduce cost: For many women in developing countries, LARCs are unavailable or are attainable at a cost 
much greater than women are able to pay. For these women, access to LARCs is dependent on 
programs largely financed by donors and national governments. Despite the relatively high 
initial cost of LARCs, developing-country governments, working with donors and NGOs, have 
expanded the level of LARC use over the past five years. To sustain this progress, manufactu-
rers, international donors, and national procurement systems should collaborate to develop 
strategies to increase the affordability of procuring and supplying LARCs. They should also 
work to maintain a reliable supply of LARCs within countries to allow use of these methods as 





To ensure that women have a range of choices across product classes, public and private 
health care delivery systems should integrate LARCs into their training, counseling, service 
provision, logistics, and information management. Because many providers of postabortion 
and postpartum care have the counseling and clinical skills needed for initiation of LARCs, 
more attention should be focused on postabortion and postpartum provision of LARCs as one 




Organizations engaged in promoting reliable access to contraceptive methods should ensure 
that long-acting, reversible contraceptive methods are available in public and private markets, 
and that products and services are accessible to women in the poorest segments of each 
country. Governments and donors should promote informed choice by supporting a variety of 
contraceptive choices rather than particular methods. 




National family planning, reproductive health, and women's health program managers should 
develop competency-based training and on-the-job supervisory systems to ensure that quali-
fied staff, both medical and paramedical, are in a position to provide counseling, insertion, and 




Professional associations, including FIGO, the International Confederation of Midwives, the 
International Council of Nurses, and similar national and regional societies should work with 
national governments and private-sector organizations to train medical and nonmedical 
providers and otherwise facilitate women’s access to information and services. 
Gather and use 




Data on the use, quality of care, and effectiveness of LARCs and other family planning methods 
in resource-limited settings should be developed or, where already available, disseminated. 
These data should be reviewed by WHO and by professional associations such as FIGO to de-
termine whether additional guidance is needed on the public health benefits of expanding use 
of LARCs. Indicators should be developed and deployed that measure the extent to which wo-
men have easy access to a range of high-quality contraceptive methods, including LARCs. 
Develop a  
strategic plan to 
accomplish 
these goals: 
Representatives of national governments, donors, contraceptive manufacturers, program ma-
nagers, NGO leaders, and representative users should meet before the end of 2012 to develop 
a detailed strategic plan, based on a joint diagnosis of the most consequential barriers to grea-
ter access and affordability of highly effective, long-acting, reversible methods. The strategic 
plan is a tool for increasing choices for women, ensuring reliable supplies, enhancing service 
quality, and improving reproductive health. 
The provision of LARCs and other contraceptives and reproductive health care must be based on 
informed choice, voluntarism, and equity. These ethical principles are critical to ensure that 
women's needs are at the center of any discussion of technologies, and are consistent with plans 
of action adopted by the International Conference on Population and Development (ICPD) in 
1994, the Conference on Women in 1995, WHO's Global Strategy on Reproductive Health in 
2004, and the UN Global Strategy for Women's and Children's Health in 2010. 
  
We ask that these actions be fully implemented by 2020, with significant progress made by 
2015 consistent with the achievement of the Millennium Development Goals. These actions will 
improve the health of women, expand their opportunities, and improve the welfare of their 
families and communities. Moreover, countries will see the economic dividends of lower fertility 
and over time a changing age structure with less dependency and greater work force participa-
tion. We ask that these recommendations form part of the analysis and discussion at the Family 
Planning Summit on July 11, 2012, in London. We ask also that the plans of action emerging 
from this summit include specific recommendations for guaranteeing informed choice and 
equity, including increased access to highly effective, long-acting, reversible contraception as 
part of a broader multi-method strategy for improving women's health and options. 
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